Trials / Completed
CompletedNCT03100136
Test Re-Test Reliability of [11C]PF-06809247 as a Novel PET Tacer
A Non-randomized, Open-label, Exploratory Study With A Non-pharmacologically Active Dose To Evaluate The Binding Kinetics Of A Novel Monoacylglicerol Lipase Positron Emission Tomography Radiotracer [11C]PF-06809247 In Healthy Male Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 7 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- Male
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
This is a study measuring the binding kinetics and test-retest characteristics of a subpharmacological dose of \[11C\]PF-06809247 Monoacylglycerol lipase (MAGL) Positron Emission Tomography (PET) tracer in healthy adult subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [11C]PF-06809247 | PET Tracer |
Timeline
- Start date
- 2016-11-16
- Primary completion
- 2017-03-10
- Completion
- 2017-03-10
- First posted
- 2017-04-04
- Last updated
- 2017-04-04
Locations
3 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03100136. Inclusion in this directory is not an endorsement.